Bristol Myers Squibb

@bmsnews · New York, New York · joined 21 Apr 2009

We work every day to transform patients’ lives through science. See our community guidelines: https://t.co/Qd22DZ1Lv4

151 075Followers

1 027Following

8 968Posts total

167.4KViews on collected posts

Latest posts

Bristol Myers Squibb@bmsnews29 Aug

#MEDIA: At the 2026 #ESCCongress, we shared new long-term and real-world data in adults with symptomatic obstructive hypertrophic cardiomyopathy, adding to real-world evidence on long-term outcomes for this patient population: https://t.co/itUPL5CSeE https://t.co/w4mSz3kCzs 2.8K views · 18 likes · 3 reposts · 2 replies Open on X →

Bristol Myers Squibb@bmsnews27 Aug

We're investing more than $173 million to expand U.S. radiopharmaceutical manufacturing capacity and help deliver next-generation cancer treatments to patients. Led by @RayzeBio, this investment will support jobs and innovation in Indiana. https://t.co/q41fxnf20x #OneBMS https:// 2.6K views · 19 likes · 3 reposts · 0 replies Open on X →

Bristol Myers Squibb@bmsnews21 Aug

@bmsnews @US_FDA #4 https://t.co/ZZ7nJaRaXB 14 views · 0 likes · 0 reposts · 0 replies Open on X →

Bristol Myers Squibb@bmsnews17 Aug

@bmsnews @US_FDA Encouraging news for people living with relapsed or refractory multiple myeloma. Every new treatment option expands possibilities and brings us closer to more precise, patient-centered care. #MultipleMyeloma #Cancer #Research 35 views · 0 likes · 0 reposts · 0 replies Open on X →

Bristol Myers Squibb@bmsnews14 Aug

@bmsnews @US_FDA This getting serious complicated ….. here is the issue big pharma is designing combinatorial drug in a vacuum of the patients immune and genetic status …..May I make a suggestion to medical establishment, FDA included, to have immune / genetic monitoring work up 44 views · 1 likes · 0 reposts · 0 replies Open on X →

Bristol Myers Squibb@bmsnews13 Aug

#MEDIA: @US_FDA granted accelerated approval to our new CELMoD treatment for relapsed or refractory #MultipleMyeloma in adults, introducing a new class of treatment. https://t.co/AjYS3vF6ac https://t.co/Tqf2BELoFy 6.3K views · 26 likes · 7 reposts · 4 replies Open on X →

Bristol Myers Squibb@bmsnews12 Aug

For more than 25 years, the BMS Foundation, an independent charitable organization, has been strengthening health systems in Africa to address adult cancers as well as pediatric cancers and blood disorders. Read how our grantees are making an impact: https://t.co/nxEOQSolOI https 1.8K views · 9 likes · 1 reposts · 0 replies Open on X →

Bristol Myers Squibb@bmsnews10 Aug

@bmsnews Why???? BMS closed/ sold major US manufacturing sites several years ago. Just bowing down to the current administration. Makes no sense 45 views · 0 likes · 0 reposts · 0 replies Open on X →

Bristol Myers Squibb@bmsnews10 Aug

#MEDIA: Today, we announced a $2.3 billion investment to build a new manufacturing campus in Houston, Texas. Read more: https://t.co/8OKBDoewsW https://t.co/Tdt3p7V5s5 10.2K views · 41 likes · 9 reposts · 2 replies Open on X →

Bristol Myers Squibb@bmsnews31 Jul

A proposed convergent molecular chain linking senescence, cancer, and chronic infection to a correctable failure of dendritic cell instruction https://t.co/gRXOlq69RV 143.6K views · 107 likes · 30 reposts · 13 replies Open on X →

Against accounts of the same size

10 posts from the last 90 days, next to the 100K–1M follower range. ordinary reach for its size, weaker reaction than most.

Median views2 194this account5 983median for 100K–1M

Reach, %1.45%this account1.49%median for 100K–1M

Engagement, %0.57%this account0.93%median for 100K–1M

Metric	This account	Median for 100K–1M	Ratio
Median views per post	2 194	5 983	0.37×
Reach (views ÷ followers)	1.45%	1.49%	0.97×
Engagement rate	0.57%	0.93%	0.61×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

143.6K31 Jul

10.2K10 Aug

1.8K12 Aug

6.3K13 Aug

4414 Aug

3517 Aug

1421 Aug

2.6K27 Aug

2.8K29 Aug

Last 10 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.11%31 Jul

0.59%10 Aug

0.00%

0.55%12 Aug

0.62%13 Aug

2.27%14 Aug

0.00%17 Aug

0.00%21 Aug

0.85%27 Aug

0.82%29 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes70.6%221 in total

Reposts16.9%53 in total

Replies6.7%21 in total

Quotes4.5%14 in total

Bookmarks1.3%4 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.